178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Li Liu, Simon Turcotte, Shari Pilon-Thomas, Doris Wiener, Brian Czerniecki, Matthew Beatty, Larissa Pikor, Urminder Singh, Christian E Laing, Jacob Gibson, Anna Kluew, Mahdi Golkaram, Sven Bilke, Nathalie Brassard, Stewart E Abbot, Timothy J Langer, Grace DeSantis, Michael J Ciancanelli, Jeff H Tsai
التنسيق:	مقال
اللغة:	English
منشور في:	BMJ Publishing Group 2023-11-01
سلاسل:	Journal for ImmunoTherapy of Cancer

مواد مشابهة

900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
حسب: Quanyuan He, وآخرون
منشور في: (2023-11-01)

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
حسب: Amy Hall, وآخرون
منشور في: (2023-11-01)

Tumor neoantigens and tumor immunotherapies
حسب: Wang Jiani, وآخرون
منشور في: (2024-04-01)

Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
حسب: Meng Jia, وآخرون
منشور في: (2023-10-01)

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.
حسب: Mahdi Golkaram, وآخرون
منشور في: (2020-11-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
حسب: Wang Wanqiu
منشور في: (2019-01-01)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
حسب: Markus W. Löffler, وآخرون
منشور في: (2019-04-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
حسب: Kim Bich Nguyen, وآخرون
منشور في: (2023-08-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
حسب: Zhe Jing, وآخرون
منشور في: (2022-08-01)

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
حسب: Stefani Spranger, وآخرون
منشور في: (2024-11-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
حسب: Vladimir Roudko, وآخرون
منشور في: (2020-01-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
حسب: Zheying Zhang, وآخرون
منشور في: (2021-04-01)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
حسب: Brandon Mistretta, وآخرون
منشور في: (2023-09-01)

Utilization of primary tumor samples for cancer neoantigen discovery
حسب: Yong Li, وآخرون
منشور في: (2025-01-01)

Tumor neoantigens: from basic research to clinical applications
حسب: Tao Jiang, وآخرون
منشور في: (2019-09-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
حسب: Yanwei Shen, وآخرون
منشور في: (2022-08-01)

Inducible de novo expression of neoantigens in tumor cells and mice
حسب: Damo, Martina, وآخرون
منشور في: (2021)

Inducible de novo expression of neoantigens in tumor cells and mice
حسب: Damo, Martina, وآخرون
منشور في: (2022)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
حسب: Truex, Nicholas, وآخرون
منشور في: (2020)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
حسب: Berta Segura-Collar, وآخرون
منشور في: (2023-05-01)

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
حسب: Zhiting Wei, وآخرون
منشور في: (2019-11-01)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
حسب: Vrunda Trivedi, وآخرون
منشور في: (2024-01-01)

The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
حسب: Shefali Mehra, وآخرون
منشور في: (2024-01-01)

Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
حسب: Xiaoyu Huang, وآخرون
منشور في: (2024-03-01)

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
حسب: Guadalupe Nibeyro, وآخرون
منشور في: (2023-07-01)

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
حسب: Berta Segura-Collar, وآخرون
منشور في: (2023-07-01)

The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
حسب: Ahmet Murat Aydin, وآخرون
منشور في: (2021-02-01)

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
حسب: Shari Pilon-Thomas, وآخرون
منشور في: (2023-10-01)

Analysis of Somatic Mutations in the TCGA-LIHC Whole Exome Sequence to Identify the Neoantigen for Immunotherapy in Hepatocellular Carcinoma
حسب: Swetha Pulakuntla, وآخرون
منشور في: (2023-12-01)

Unraveling the power of NAP-CNB’s machine learning-enhanced tumor neoantigen prediction
حسب: Almudena Mendez-Perez, وآخرون
منشور في: (2025-03-01)

TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
حسب: Jingcheng Wu, وآخرون
منشور في: (2018-08-01)

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
حسب: Celina Tretter, وآخرون
منشور في: (2023-08-01)

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
حسب: Kai Xin, وآخرون
منشور في: (2024-12-01)

Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy
حسب: Ting Su, وآخرون
منشور في: (2023-08-01)

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
حسب: Jiangping Li, وآخرون
منشور في: (2023-08-01)

Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
حسب: Songming Peng, وآخرون
منشور في: (2019-09-01)

TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
حسب: Yunxia Tang, وآخرون
منشور في: (2020-11-01)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
حسب: Manisit Das, وآخرون
منشور في: (2020-12-01)

The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
حسب: Sang Hoon Kim, وآخرون
منشور في: (2024-06-01)

1461 Induction of clonal expansion of tumor-reactive T cells and effective tumor suppression by neoantigens predicted from the ‘VACINUS‘ platform
حسب: Sang Hoon Kim, وآخرون
منشور في: (2023-11-01)